Completed from United Kingdom
I took this course because I wanted a solid grounding in health economics before starting my MSc. The content was spot‑on – especially the sections on willingness‑to‑pay and QALY calculations. I loved the hands‑on workshops where we used R to run sensitivity analyses on a simulated vaccine rollout. The course pack was packed with real‑world examples from the NHS, which made the theory feel immediately useful. I left feeling confident that I could contribute to HTA reports at my job, and the supportive teaching style made the whole experience enjoyable.
The Pharmaceutical Health Economics course at Stanmore School of Business perfectly aligned with my goal of moving into health‑policy analysis. The modules on cost‑effectiveness analysis gave me a step‑by‑step framework that I immediately applied to a real‑world case study on a new oncology drug. The lecture slides were concise, and the supplementary reading from the UK NICE guidelines was extremely relevant. By the end of the term I could build a budget‑impact model in Excel, which impressed my current employer and led to a project assignment on pricing strategy. Overall, the instruction was professional and the materials were top‑notch – I feel fully prepared for the next stage of my career.
Wow! This course blew my expectations out of the water. I was looking for practical tools to help me evaluate drug pricing in emerging markets, and the instructors delivered exactly that. The live case study on a diabetes medication gave me the chance to create a full cost‑utility model using Excel and then present my findings to a mock review board. The reading list, which included WHO HTA resources, was incredibly relevant to my work in India. I’m now able to confidently discuss budget impact with senior managers, and I’m thrilled with the knowledge I gained. Highly recommend for anyone who wants to dive deep into health economics.
The Pharmaceutical Health Economics module was exceptionally detailed, covering everything from basic health‑economic theory to advanced pharmacoeconomic modelling. I appreciated the systematic breakdown of the incremental cost‑effectiveness ratio (ICER) and the way the course integrated South African case studies, which made the material directly applicable to my role in a public‑health agency. The provided data sets allowed me to practice building Markov models, and the feedback on my assignments was thorough. Overall, the course materials were high‑quality, the instructors were knowledgeable, and I left with a concrete set of analytical skills that I am already using in policy development.
